Nivolumab treatment for oesophageal squamous-cell carcinoma: an open-label, multicentre, phase 2 trial - Kudo, T; Hamamoto, Y; Kato, K (Lancet Oncol, 2017)
. doi:10.1016/S1470-2045(17)30181-X